症例から学ぶ　輸入感染症　A to Z　ver.2

出版社： 中外医学社
著者：
発行日： 2019-04-15
分野： 臨床医学：内科  >  感染症/AIDS
ISBN： 9784498021235
電子書籍版： 2019-04-10 （2版1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

6,380 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

6,380 円(税込)

購入する

商品紹介

海外渡航者やインバウンドが増加し続ける現在、いかなる医療機関においても輸入感染症に遭遇する可能性は少なくありません。大幅改訂となったver.2では、マラリアやデング熱などのメジャーな疾患から近年話題のジカウイルス感染症やエボラウイルス病、さらには見落としてはいけないマイナーな感染症まで、国内で遭遇しうる輸入感染症の診療について忽那、上村の師弟コンビがさらにゆる〜く解説します。

目次

  • 各感染症の流行地域と潜伏期間
    　はじめに〜日本を取り巻く輸入感染症
    　海外渡航歴を取ろう！
    　　 ポケモンGO
    　渡航地はどこだ！
    　潜伏期から絞り込もう
    　曝露歴をしっかり聴取しよう！
    　ちゃばい感染症を除外しろッ！！
    　隔離すべき感染症を除外しろッ！！
    　身体所見と検査所見，特徴があれば儲けもの
    　マラリア，マラリア，そしてマラリア
    　　第6のマラリア
    　　non-immuneだとリアメットによる治療後の再燃が多い？　
    　　ヨーロッパでマラリアに感染？　その1
    　　ヨーロッパでマラリアに感染？　その2
    　　学会を作ってみた
    　デングとその仲間たち
    　　チクングニアとジカの次に来るのはどれだ！？
    　季節外れ？
    　　熱帯医学の短期研修
    　渡航歴があるからこそ性交渉歴を！
    　たかが下痢症，されど下痢症
    　　キャンピロバクター腸炎は辛い！
    　下痢，ときどき便秘……？
    　輸入感染症ではオッカムのかみそりの切れ味が悪い
    　ジカにまつわるエトセトラ
    　　輸入感染症は症例報告の宝庫！
    　　検疫所って何するところ？
    　海外での入院歴は要注意！
    　海外で犬に咬まれたら
    　　コアラに咬まれたら
    　渡航歴がなくても
    　　ドイツ人中年女性は日本のどこでデング熱に感染したのか？
    　　お寺とオレ
    　鳥に気をつけろッ！
    　ウイルス性出血熱
    　　日本唯一のウイルス性出血熱の症例
    　バイオテロって起こりえますか？
    　ガチなヤツに気をつけろッ！
    　結核を見逃すなッ！
    　MERSに気をつけろッ！
    　最終試験
    　　日本でも土着回帰熱？
    　　日本海に浮かぶ無人島にまだ誰も罹ったことのない回帰熱ボレリアが……？

    輸入感染症早見表

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

A はじめに～日本を取り巻く輸入感染症

P.5 掲載の参考文献
(1) Kanai M, Kamiya H, Smith-Palmer A, et al. Meningococcal disease outbreak related to the World Scout Jamboree in Japan, 2015. Western Pac Surveill Response J. 2017 ; 8 : 25-30.
 
(2) Gautret P, Steffen R. Communicable diseases as health risks at mass gatherings other than Hajj : what is the evidence? Int J Infect Dis. 2016 ; 47 : 46-52.
PubMed
(3) Kutsuna S, Kato Y, Moi ML, et al. Autochthonous dengue fever, Tokyo, Japan, 2014. Emerg Infect Dis. 2015 ; 21 : 517-20.
PubMed

B 海外渡航歴を取ろう !

P.12 掲載の参考文献
(1) Call SA, Vollenweider MA, Hornung CA, et al. Does this patient have influenza? JAMA. 2005 ; 293 : 987-97.
PubMed
(2) Freedman DO, Weld LH, Kozarsky PE, et al ; GeoSentinel Surveillance Network. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med. 2006 ; 354 : 119-30.
PubMed

C 渡航地はどこだ !

P.23 掲載の参考文献
(1) Leder K, Torresi J, Libman MD, et al. GeoSentinel Surveillance Network. GeoSentinel surveillance of illness in returned travelers, 2007-2011. Ann Intern Med. 2013 ; 158 : 456-68.
PubMed
(2) Kutsuna S, Hayakawa K, Kato Y, et al. Comparison of clinical characteristics and laboratory findings of malaria, dengue, and enteric fever in returning travelers : 8-year experience at a referral center in Tokyo, Japan. J Infect Chemother. 2015 Dec 18. pii : S1341-321X (14) 00418-8.
 
(3) Johnston V, Brown M. Fever in the Returned Traveler. In : Magill AJ, Ryan ET, Hill D, eds. Hunter's Tropical Medicine and Emerging Infectious Diseases. 9th ed. Philadelphia : Saunders Elsevier ; 2012. p. 1021-31.
 

D 潜伏期から絞り込もう

P.27 掲載の参考文献
(1) Spira AM. Assessment of travellers who return home ill. Lancet. 2003 ; 361 : 1459-69.
PubMed
(2) Ooi EE, Gubler DJ. Dengue and Dengue hemorrhagic fever. In : Guerrant RL, Walker DH, Weller PF, eds. Guerrant tropical infectious diseases-principles, pathogens and practice. 3rd ed. St Louis : Saunders ; 2011. p. 504-10.
 

E 曝露歴をしっかり聴取しよう !

P.39 掲載の参考文献
(1) Hatz C, Chen LH. Pre-travel consultation. In : Keystone JS, Kozarsky PE, Freedman DO, eds. Travel medicine. 3rd ed. Edinburgh : Mosby ; 2013. p. 31-6.
 
(2) A型肝炎-2006-2008年. IDWR. 2009 ; 12.
 
(3) Jong EC. Approach to travel medicine and a personal travel medicine kit. In : Jong EC. Jong travel and tropical medicine manual. 4th ed. Philadelphia : Saunders ; 2008. p. 1-17.
 
(4) Fradin MS, Day JF. Comparative efficacy of insect repellents against mosquito bites. N Engl J Med. 2002 ; 347 : 13.
PubMed
(5) Spira AM. Assessment of travellers who return home ill. Lancet. 2003 ; 361 : 1459-69.
PubMed
(6) Matteelli A, Carosi G. Sexually transmitted diseases in travelers. Clin Infect Dis. 2001 ; 32 : 1063-7.
PubMed
(7) Vivancos R, Abubakar I, Hunter PR. Foreign travel, casual sex, and sexually transmitted infections : systematic review and meta-analysis. Int J Infect Dis. 2010 ; 14 : e842-51.
PubMed
(8) CDC. Outbreak of acute febrile illness among athletes participating in triathlons-Wisconsin and Illinois, 1998. Morb Mortal Wkly Rep. 1998 ; 47 : 585-8.
PubMed
(9) Kutsuna S, Kato Y, Koizumi N, et al. Travel-related leptospirosis in Japan : A report on a series of five imported cases diagnosed at the National Center for Global Health and Medicine. J Infect Chemother. 2015 ; 21 : 218-23.
PubMed
(10) Wilder-Smith A. Meningococcal vaccine in travelers. Curr Opin Infect Dis. 2007 ; 20 : 454-60.
PubMed
(11) Anwar E, Goldberg E, Fraser A, et al. Vaccines for preventing typhoid fever. Cochrane Database Syst Rev. 2014 ; 1 : CD001261.
PubMed
(12) Romi R, Sabatinelli G, Majori G. Malaria epidemiological situation in Italy and evaluation of malaria incidence in Italian travelers. J Travel Med. 2001 ; 8 : 6-11.
PubMed

F ちゃばい感染症を除外しろッ ! !

P.48 掲載の参考文献
(1) 岡部信彦. 一類感染症. 臨床と微生物. 2008 ; 35 : 217-22.
Medical*Online
(2) Thwaites GE, Day NP. Approach to fever in the returning traveler. N Engl J Med. 2017 ; 376 : 548-60.
PubMed

G 隔離すべき感染症を除外しろッ ! !

P.57 掲載の参考文献
(1) Currie J, Davies L, McCarthy J, et al. Measles outbreak linked to European B3 outbreaks, Wales, United Kingdom, 2017. Euro Surveill. 2017 ; 22 (42).
PubMed
(2) Filia A, Bella A, Del Manso M, et al. Ongoing outbreak with well over 4,000 measles cases in Italy from January to end August 2017-what is making elimination so difficult? Euro Surveill. 2017 ; 22 (37). pii30613.
PubMed
(3) 加藤博史, 今村顕史, 関谷紀貴, 他. 成人における風疹の臨床像についての検討. 感染症学雑誌. 2013 ; 87 : 603-7.
 
(4) Kunimatsu J, Kanehisa E, Yamamoto K, et al. Adult rubella : a retrospective analysis of 45 cases. ID week 2013.
 

H 身体所見と検査所見, 特徴があれば儲けもの

P.73 掲載の参考文献
(1) Johnston V, Brown M. Fever in the returned traveler. In : Magill AJ, Ryan ET, Hill D, eds. Hunter's tropical medicine and emerging infectious diseases. 9th ed. Philadelphia : Saunders Elsevier ; 2012. p. 1021-31.
 
(2) Kyaw MH, Holmes EM, Toolis F, et al. Evaluation of severe infection and survival after splenectomy. Am J Med 2006 ; 119 : 276. e1.
 
(3) Harris JB, Brooks WA. Typhoid and paratyphoid (enteric) fever. In : Magill AJ, Ryan ET, Hill D, eds. Hunter's tropical medicine and emerging infectious diseases. 9th ed. Philadelphia : Saunders Elsevier ; 2012. p. 568-79.
 
(4) 大曲貴夫. 感染症診療のロジック 患者さんのモンダイを解決するキホンとアプローチ法. 東京 : 南山堂 ; 2010.
 
(5) Kutsuna S, Kato Y, Koizumi N, et al. Travel-related leptospirosis in Japan : a report on a series of five imported cases diagnosed at the National Center for Global Health and Medicine. J Infect Chemother. 2015 ; 21 : 218-23.
PubMed
(6) Leder K, Torresi J, Libman MD, et al ; GeoSentinel Surveillance Network. GeoSentinel surveillance of illness in returned travelers, 2007-2011. Ann Intern Med. 2013 ; 158 : 456-68.
PubMed
(7) Amilasan AS, Ujiie M, Suzuki M, et al. Outbreak of leptospirosis after flood, the Philippines, 2009. Emerg Infect Dis. 2012 ; 18 : 91-4.
PubMed
(8) Sejvar J, Bancroft E, Winthrop K, et al. Lepto-spirosis in "Eco-Challenge" athletes, Malaysian Borneo, 2000. Emerg Infect Dis. 2003 ; 9 : 702-7.
 
(9) Matono T, Kutsuna S, Koizumi N, et al. Imported flood-related Leptospirosis from Palau : awareness of risk factors leads to early treatment. J Travel Med. 2015 ; 22 : 422-4.
PubMed
(10) Haake DA, Levett PN. Leptospira species (leptospirosis). In : Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 8th ed. Philadelphia : Churchill Livingstone ; 2014. p. 2714-20.
 

I マラリア, マラリア, そしてマラリア

P.123 掲載の参考文献
(1) Brunette GW. CDC Yellow Book 2018 : health information for international travel. Oxford University Press ; 2017.
 
(2) Wilder-Smith A. Meningococcal vaccine in travelers. Curr Opin Infect Dis. 2007 ; 20 : 454-60.
PubMed
(3) Bailey JW, Williams J, Bain BJ, et al ; General Haematology Task Force of the British Committee for Standards in Haematology. Guideline : the laboratory diagnosis of malaria. Br J Haematol. 2013 ; 163 : 573-80.
PubMed
(4) Sinclair D, Donegan S, Isba R, et al. Artesunate versus quinine for treating severe malaria. Cochrane Database of Systematic Reviews. 2012 ; 6 : CD005967.
PubMed
(5) Chen LH, Wilson ME, Schlagenhauf P. Controversies and misconceptions in malaria chemoprophylaxis for travelers. JAMA. 2007 ; 297 : 2251-63.
PubMed
(6) Food U, Administration D. FDA approves label changes for antimalarial drug mefloquine hydrochloride due to risk of serious psychiatric and nerve side effects. 2016.
 
(7) Koene H, Spong K, Overbosch D. The safety and tolerance of atovaquone/proguanil for the long-term prophylaxis of plasmodium falciparum malaria in non-immune travelers and expatriates [corrected]. J Travel Med. 2007 ; 14 : 92-5.
 
(8) Strickland GT. Hunter's tropical medicine and emerging infectious diseases. WB Saunders ; 2000.
 
(9) Steffen R, Fuchs E, Schildknecht J, et al. Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting East Africa. Lancet. 1993 ; 341 : 1299-303.
PubMed
(10) Farcas GA, Zhong KJ, Lovegrove FE, et al. Evaluation of the Binax NOW ICT test versus polymerase chain reaction and microscopy for the detection of malaria in returned travelers. Am J Trop Med Hyg. 2003 ; 69 : 589-92.
PubMed
(11) Tanizaki R, Kato Y, Iwagami M, et al. Performance of rapid diagnostic tests for Plasmodium ovale malaria in Japanese travellers. Trop Med Health. 2014 ; 42 : 149-53.
PubMed
(12) Askling HH, Bruneel F, Burchard et al. Management of imported malaria in Europe. Malar J. 2012 ; 11 : 328-32.
PubMed
(13) Organization WH. World health organization guidelines for the treatment of malaria. http://wwwwhoint/malaria/dics/TreatmentGuidelines2006pdf. 2006.
 
(14) Schwartz E, Parise M, Kozarsky P, et al. Delayed onset of malaria-implications for chemoprophylaxis in travelers. N Engl J Med. 2003 ; 349 : 1510-6.
PubMed
(15) Tanizaki R, Ujiie M, Kato Y, et al. First case of Plasmodium knowlesi infection in a Japanese traveller returning from Malaysia. Malar J. 2013 ; 12 : 128.
 
(16) Wilson ME, Kantele A, Jokiranta TS. Review of cases with the emerging fifth human malaria parasite, Plasmodium knowlesi. Clin Infect Dis. 2011 ; 52 : 1356-62.
 
(17) Takaya S, Kutsuna S, Suzuki T, et al. Case report : Plasmodium knowlesi Infection with rhabdomyolysis in a Japanese traveler to Palawan, the Philippines. The Am J Trop Med Hyg. 2018 ; 99 : 967-9.
 
P.124 掲載の参考文献
(1) Brasil P, Zalis MG, de Pina-Costa A, et al. Outbreak of human malaria caused by Plasmodium simium in the Atlantic Forest in Rio de Janeiro : a molecular epidemiological investigation. Lancet Glob Health. 2017 ; 5 : e1038-e46.
 
P.125 掲載の参考文献
(1) Sonden K, Wyss K, Jovel I, et al. High rate of treatment failures in nonimmune travelers treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Sweden : retrospective comparative analysis of effectiveness and case series. Clin Infect Dis. 2016 ; 64 : 199-206.
PubMed
(2) 忽那賢志, 小林泰一郎, 加藤康幸, 他. アーテメター・ルメファントリン合剤の日本人における使用経験. 感染症学雑誌. 2014 ; 88 : 833-9.
 
(3) Nakamura-Uchiyama F, Katanami Y, Kikuchi T, et al. Retrospective observational study of the use of artemether-lumefantrine in the treatment of malaria in Japan. Travel medicine and infectious disease. 2018 ; 22 : 40-5.
PubMed
P.126 掲載の参考文献
(1) BBC news. Rare malaria death of girl in northern Italy puzzles doctors. 5 September 2017. https://www.bbc.com/news/world-europe-41161133
 
(2) Mail Online. Italy opens manslaughter probe over four-year-old girl's malaria death as prosecutors fear she could have caught it from a reused needle at the hospital. https://www.dailymail.co.uk/news/article-4862636/Italy-opens-manslaughter-probegirl-s-malaria-death.html
 
(3) European Centre for Disease Prevention and Control. Rapid risk assessment : Hospitalacquired malaria infections in the European Union.
 
(4) 神前昌敏. 輸血後バベシア症の本邦第一例. 日輸血会誌. 2000.
Medical*Online
P.128 掲載の参考文献
(1) Benelli G, Pombi M, Otranto D. Malaria in Italy-migrants are not the cause. Trends Parasitol. 2018 ; 34 : 351-4.
 
(2) Ashley EA, White NJ. The duration of Plasmodium falciparum infections. Malaria J. 2014 ; 13 : 500.
PubMed
(3) Zammarchi L, Di Lauria N, Bartalesi F, et al. Cryptic severe Plasmodium falciparum malaria in a Moroccan man living in Tuscany, Italy, August 2018. Euro Surveill. 2018 ; 23 (41).
 
(4) Medialdea-Carrera R, Melillo T, Gauci C, et al. Letter to the editor : Is malaria re-emerging in southern Europe? Cryptic Plasmodium falciparum malaria in Malta, October 2018. Euro Surveill. 2018 ; 23 (50).
 
(5) Elbadry MA, Al-Khedery B, Tagliamonte MS, et al. High prevalence of asymptomatic malaria infections : a cross-sectional study in rural areas in six departments in Haiti. Malaria J. 2015 ; 14 : 510.
PubMed
(6) Lin JT, Saunders DL, Meshnick SR. The role of submicroscopic parasitemia in malaria transmission : what is the evidence? Trends Parasitol. 2014 ; 30 : 183-90.
PubMed
(7) Pousibet-Puerto J, Cabezas-Fernandez MT, Lozano-Serrano AB, et al. Submicroscopic Malaria in migrants from Sub-Saharan Africa, Spain. Emerging Infect Dis. 2019 ; 25 : 349-52.
 
(8) ECDC. Rapid risk assessment : Multiple reports of locally-acquired malaria infections in the EU. https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessmentmultiple-reports-locally-acquired-malaria-infections-eu
 
P.130 掲載の参考文献
(1) Kutsuna S, Hayakawa K. Rubella rash. N Engl J Med. 2013 ; 369 : 558.
 
(2) Fuchizaki U, Nishikawa M. Gastric Anisakiasis. N Engl J Med. 2016 ; 375 : e11.
PubMed

J デングとその仲間たち

P.162 掲載の参考文献
(1) Brunette GW. CDC Yellow Book 2018 : health information for international travel. Oxford University Press ; 2017.
 
(2) Menard D, Khim N, Beghain J, et al. A worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N Engl J Med. 2016 ; 374 : 2453-64.
PubMed
(3) Uchihara T, Tsukagoshi H. Jolt accentuation of headache : the most sensitive sign of CSF pleocytosis. Headache. 1991 ; 31 : 167-71.
PubMed
(4) Attia J, Hatala R, Cook DJ, et al. Does this adult patient have acute meningitis? JAMA. 1999 ; 282 : 175-81.
PubMed
(5) Tamune H, Takeya H, Suzuki W, et al. Absence of jolt accentuation of headache cannot accurately rule out meningitis in adults. Am J Emerg Med. 2013 ; 31 : 1601-4.
PubMed
(6) Nakao JH, Jafri FN, Shah K, et al. Jolt accentuation of headache and other clinical signs : poor predictors of meningitis in adults. Am J Emerg Med. 2014 ; 32 : 24-8.
PubMed
(7) Kutsuna S, Hayakawa K, Kato Y, et al. Comparison of clinical characteristics and laboratory findings of malaria, dengue, and enteric fever in returning travelers : 8-year experience at a referral center in Tokyo, Japan. J Infecti Chemother. 2015 ; 21 : 272-6.
 
(8) Suzuki T, Kutsuna S, Taniguchi S, et al. Dengue Virus Exported from Cote d'Ivoire to Japan, June 2017. Emerg Infect Dis. 2017 ; 23 : 1758.
PubMed
(9) Halsey ES, Vilcarromero S, Forshey BM, et al. Performance of the tourniquet test for diagnosing dengue in Peru. Am J Trop Med Hyg. 2013 ; 89 : 99-104.
PubMed
(10) Cobra C, Rigau-Perez JG, Kuno G, et al. Symptoms of dengue fever in relation to host immunologic response and virus serotype, Puerto Rico, 1990-1991. Am J Epidemiol. 1995 ; 142 : 1204-11.
PubMed
(11) Kutsuna S, Ohmagari N. Dengue fever. Intern Med. 2014 ; 53 : 1727.
PubMed
(12) Kutsuna S, Hayakawa K, Kato Y, et al. The usefulness of serum C-reactive protein and total bilirubin levels for distinguishing between dengue fever and malaria in returned travelers. Am J Trop Med Hyg. 2014 ; 90 : 444-8.
 
(13) Simmons CP, Farrar JJ, Nguyen vV, et al. Dengue. N Engl J Med. 2012 ; 366 : 1423-32.
PubMed
(14) Fry SR, Meyer M, Semple MG, et al. The diagnostic sensitivity of dengue rapid test assays is significantly enhanced by using a combined antigen and antibody testing approach. PLoS Negl Trop Dis. 2011 ; 5 : e1199.
PubMed
(15) 的野多加志, 忽那賢志, 加藤康幸, 他. 予期せぬ診断となったデングウイルスIgM抗体偽陽性の2例. 感染症学雑誌. 2016 ; 90 : 125-8.
 
(16) Dengue : guidelines for diagnosis, treatment, prevention and control : World Health Organization ; 2009.
 
(17) Thein S, Aung MM, Shwe TN, et al. Risk factors in dengue shock syndrome. Am J Trop Med Hyg. 1997 ; 56 : 566-72.
PubMed
(18) Kendrick K, Stanek D, Blackmore C. Notes from the field : Transmission of chikungunya virus in the continental United States--Florida, 2014. MMWR Morb Mortal Wkly Rep. 2014 ; 63 : 1137.
PubMed
(19) Fischer M, Staples JE. Chikungunya virus spreads in the Americas-Caribbean and South America, 2013-2014. MMWR Morb Mortal Wkly Rep. 2014 ; 63 : 500.
PubMed
(20) Staples JE, Breiman RF, Powers AM. Chikungunya fever : an epidemiological review of a re-emerging infectious disease. Clin Infect Dis. 2009 ; 49 : 942-8.
PubMed
(21) Lee VJ, Chow A, Zheng X, et al. Simple clinical and laboratory predictors of Chikungunya versus dengue infections in adults. PLoS Negl Trop Dis. 2012 ; 6 : e1786.
PubMed
(22) Kutsuna S, Kato Y, Katanami Y, et al. A retrospective single-center analysis of 16 cases of imported Chikungunya fever in Japan. Intern Med. 2018 ; 57 : 325-8.
PubMed
(23) Rezza G, Nicoletti L, Angelini R, et al. Infection with chikungunya virus in Italy : an outbreak in a temperate region. Lancet. 2007 ; 370 : 1840-6.
 
P.165 掲載の参考文献
(1) Halsey ES, Siles C, Guevara C, et al. Mayaro virus infection, Amazon Basin Region, Peru, 2010-2013. Emerg Infect Dis. 2013 19 : 1839-42.
 
(2) Lednicky J, De Rochars VM, Elbadry M, et al. Mayaro virus in child with acute febrile Illness, Haiti, 2015. Emerg Infect Dis. 2016 ; 22 : 2000-2.
PubMed

K 季節外れ ?

P.174 掲載の参考文献
(1) Freedman DO, Leder K. Influenza : changing approaches to prevention and treatment in travelers. J Travel Med. 2005 ; 12 : 36-44.
PubMed
(2) Miyamoto A, Watanabe S. Posterior pharyngeal wall follicles as early diagnostic marker for seasonal and novel influenza. General Medicine. 2011 ; 12 : 51-60.
 
(3) Kutsuna S, et al. Spectrum of respiratory pathogens detected by multiplex PCR in a study of respiratory tract infections among travelers. ID week 2018.
 

L 渡航歴があるからこそ性交渉歴を !

P.191 掲載の参考文献
(1) Spira AM. Assessment of travellers who return home ill. Lancet. 2003 ; 361 : 1459-69.
PubMed
(2) 岸本暢将. すぐに使えるリウマチ・膠原病診療マニュアル. 東京 : 羊土社 ; 2009. p. 78-85.
 
(3) 上野征夫. リウマチ病診療ビジュアルテキスト. 第2版. 東京 : 医学書院 ; 2008. p. 9.
 
(4) Smith JW, Chalupa P, Shabaz Hasan M. Infectious arthritis : clinical features, laboratory findings and treatment. Clin Microbiol Infect. 2006 ; 12 : 309-14.
PubMed
(5) Centers for Disease Control and Prevention. A guide to taking a sexual history. http://www.cdc.gov/std/treatment/SexualHistory.pdf
 
(6) 木原正博, 木原雅子, 内野英幸, 他. 日本人のHIV/STD関連知識, 性行動, 性意識についての全国調査, 平成11年度厚生科学研究費補助金エイズ対策研究事業「HIV感染症の疫学研究」研究報告書. 2000. p. 565-83.
 
(7) 塩野徳史, 市川誠一, 金子典代, 他. 日本成人男性におけるMSM (Men who have sex with men) 人口の推定 (会議録). 日エイズ会誌. 2009 ; 11 : 427.
 
(8) Schmidt AJ, Rockstroh JK, Vogel M, et al. Trouble with bleeding : risk factors for acute hepatitis C among HIV-positive gay men from Germany-a case-control study. PLoS One. 2011 ; 6 : e17781.
 
(9) Vittinghoff E, Douglas J, Judson F, et al. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol. 1999 ; 150 : 306.
PubMed
(10) 武市朗子, 畠山修司, 樫山鉄矢, 他. 男性同性愛者における急性A型肝炎の流行についての検討. 感染症学雑誌. 2000 ; 74 : 716-9.
 
(11) Rysgaard CD, Morris CS, Drees D, et al. Positive hepatitis B surface antigen tests due to recent vaccination : a persistent problem. BMC Clin Pathol. 2012 ; 12 : 15.
PubMed
(12) Matteelli A, Carosi G. Sexually transmitted diseases in travelers. Clin Infect Dis. 2001 ; 32 : 1063-7.
PubMed
(13) Vivancos R, Abubakar I, Hunter PR. Foreign travel, casual sex, and sexually transmitted infections : systematic review and meta-analysis. Int J Infect Dis. 2010 ; 14 : e842-51.
PubMed

M たかが下痢症, されど下痢症

P.219 掲載の参考文献
(1) Jong EC. Traveler's diarrhea : prevention and self-treatment. In : Jong EC. Jong travel and tropical medicine manual. 4th ed. Philadelphia : Saunders ; 2008. p. 1-17.
 
(2) Riddle MS, Sanders JW, Putnam SD, et al. Incidence, etiology and impact of diarrhea among long-term travelers (US military and similar populations) : a systematic review. Am J Trop Med Hyg. 2006 ; 74 : 891-900.
PubMed
(3) Ruiz J, Marco F, Oliveira I, et al. Trends in antimicrobial resistance in Campylobacter spp. causing traveler's diarrhea. APMIS. 2007 ; 115 : 218-24.
PubMed
(4) Hakanen A, Jousimies-Somer H, Siitonen A, et al. Fluoroquinolone resistance in Campylobacter jejuni isolates in travelers returning to Finland : association of ciprofloxacin resistance to travel destination. Emerg Infect Dis. 2003 ; 9 : 267-70.
PubMed
(5) 成田雅. 便グラム染色. 感度と特異度からひもとく感染症診療のDecision Making. 東京 : 文光堂 ; 2012. p. 81-4.
 
(6) DuPont AW. Postinfectious irritable bowel syndrome. Clin Infect Dis. 2008 ; 46 : 594-9.
PubMed
(7) Wright SG. Persistent diarrhea in the returned traveler. In : Magill AJ, Ryan ET, Hill D, eds. Hunter's tropical medicine and emerging infectious diseases. 9th ed. Philadelphia : Saunders Elsevier ; 2012. p. 1041-3.
 
(8) Reisinger EC, Fritzsche C, Krause R, et al. Diarrhea caused by primarily non-gastrointestinal. Nat Clin Pract Gastroenterol Hepatol. 2005 ; 2 : 216-22.
PubMed
(9) 忽那賢志, 他. アーテメター・ルメファントリン合剤の日本人における使用経験. 感染症学雑誌. 2014 ; 88 : 833-9.
 
(10) Sonden, K, Wyss K, Jovel I, et al. High rate of treatment failures in nonimmune travelers treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Sweden : retrospective comparative analysis of effectiveness and case series. Clin Infect Dis. 2016 ; 64 : 199-206.
PubMed
(11) Nakamura-Uchiyama F, Katanami Y, Kikuchi T, et al. Retrospective observational study of the use of artemether-lumefantrine in the treatment of malaria in Japan. Travel Med Infect Dis. 2018 ; 22 : 40-5.
PubMed
P.221 掲載の参考文献
(1) Blaser MJ, Berkowitz ID, LaForce FM, et al. Campylobacter enteritis : clinical and epidemiologic features. Ann Intern Med. 1979 ; 91 : 179.
PubMed
(2) 小野一晃. 市販鶏肉のカンピロバクター及びサルモネラ汚染状況と分離株の薬剤感受性. 日獣医師会誌. 2014 ; 67 : 442-8.
 
(3) Black RE, Levine MM, Clements ML, et al. Experimental Campylobacter jejuni infection in humans. J Infect Dis. 1988 ; 157 : 472-9.
PubMed

N 下痢, ときどき便秘…… ?

P.236 掲載の参考文献
(1) Anderson PT. Magnolia : The shooting script. Newmarket Shooting Scripts ; 2000.
 
(2) Cunha BA. The diagnostic significance of relative bradycardia in infectious disease. Clin Microbiol Infec. 2000 ; 6 : 633-4.
 
(3) Kutsuna S, Hayakawa K, Kato Y, et al. Comparison of clinical characteristics and laboratory findings of malaria, dengue, and enteric fever in returning travelers : 8-year experience at a referral center in Tokyo, Japan. J Infect Chemother. 2015 ; 21 : 272-6.
 
(4) Menezes GA, Harish BN, Khan MA, et al. Antimicrobial resistance trends in blood culture positive Salmonella Typhi isolates from Pondicherry, India, 2005-2009. Clin Microbiol Infect. 2012 ; 18 : 239-45.
PubMed
(5) Mohanty S, Renuka K, Sood S, et al. Antibiogram pattern and seasonality of Salmonella serotypes in a North Indian tertiary care hospital. Epidemiol Infect. 2006 ; 134 : 961-6.
 
(6) Asna S, Haq JA, Rahman MM. Nalidixic acid-resistant Salmonella enterica serovar Typhi with decreased susceptibility to ciprofloxacin caused treatment failure : a report from Bangladesh. Jpn Infect Dis. 2003 ; 56 : 32-3.
PubMed
(7) Rupali P, Abraham O, Jesudason MV, et al. Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi. Diagn Microb Infect Dis. 2004 ; 49 : 1-3.
 
(8) Wayne P. Clinical and laboratory standards institute. Performance standards for antimicrobial susceptibility testing. 2011.
 
(9) Humphries RM, Fang FC, Aarestrup FM, et al. In vitro susceptibility testing of fluoroquinolone activity against Salmonella : recent changes to CLSI standards. Clin Infect Dis. 2012 ; 55 : 1107-13.
PubMed
(10) Clinical Laboratory Standards Institute. 2013. Performance standards for antimicrobial susceptibility testing. M100-S23. CLSI, Wayne, PA, USA.
 
(11) Frenck RW Jr, Nakhla I, Sultan Y, et al. Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. Clin Infect Dis. 2000 ; 31 : 1134-8.
PubMed
(12) Girgis NI, Sultan Y, Hammad O, et al. Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug-resistant Salmonella typhi septicemia in children. Pediatr Infect Dis J. 1995 ; 14 : 603-5.
PubMed
(13) Magill AJ. Hunter's Tropical Medicine and Emerging Infectious Disease, Expert Consult-Online and Print, 9 : Hunter's Tropical Medicine and Emerging Infectious Disease. Elsevier Health Sciences ; 2013.
 
(14) Katanami Y, Kutsuna S, Morita M, et al. Six cases of Paratyphoid fever due to Salmonella Paratyphi A in travelers returning from Myanmar between July 2014 and August 2015. Am J Trop Med Hyg. 2016 ; 95 : 571-3.
PubMed
(15) Kim J-H, Mogasale V, Im J, et al. Updated estimates of typhoid fever burden in sub-Saharan Africa. Lancet Glob Health. 2017 ; 5 : e969.
PubMed
(16) Hassing R-J, Goessens WH, van Pelt W, et al. Salmonella subtypes with increased MICs for azithromycin in travelers returned to The Netherlands. Emerg Infect Dis. 2014 ; 20 : 705-8.
 
(17) Kobayashi T, Hayakawa K, Mawatari M, et al. Case report : failure under azithromycin treatment in a case of bacteremia due to Salmonella enterica Paratyphi A. BMC Infect Dis. 2014 ; 14 : 404.
 
(18) Mawatari M, Kato Y, Hayakawa K, et al. Salmonella enterica serotype Paratyphi A carrying CTX-M-15 type extended-spectrum beta-lactamase isolated from a Japanese traveller returning from India, Japan, July 2013. Eurosurveillance. 2013 ; 18. pii : 20632.
 
(19) Jin C, Gibani MM, Moore M, et al. Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi : a randomised controlled, phase 2b trial. Lancet. 2017 ; 390 : 2472-80.
PubMed

O 輸入感染症ではオッカムのかみそりの切れ味が悪い

P.246 掲載の参考文献
(1) 岡藤輝夫, 黒木春郎, 西村直子, 他. LoopampR百日咳菌 検出試薬キットDの臨床的評価. 診療と新薬. 2015 ; 52 : 1133-40.
 
(2) Centers for Disease Control and Prevention. Pertussis (Whooping Cough) : Treatment. http://www.cdc.gov/pertussis/clinical/treatment.html (Accessed on April 16, 2018)
 

P ジカにまつわるエトセトラ

P.266 掲載の参考文献
(1) Kantele A, Laaveri T, Mero S, et al. Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae. Clin Infect Dis. 2015 ; 60 : 837-46.
PubMed
(2) Hayes EB. Zika virus outside Africa. Emerg Infect dis. 2009 ; 15 : 1347-50.
PubMed
(3) Kutsuna S, Kato Y, Takasaki T, et al. Two cases of Zika fever imported from French Polynesia to Japan, December 2013 to January 2014 [corrected]. Euro Surveill. 2014 ; 19. pii : 20683.
 
(4) Chen LH, Hamer DH. Zika virus : rapid spread in the Western hemisphere. Ann Intern Med. 2016 ; 164 : 613-5.
PubMed
(5) Petersen LR, Jamieson DJ, Powers AM, et al. Zika virus. N Engl J Med. 2016 ; 374 : 1552-63.
PubMed
(6) Cerbino-Neto J, Mesquita EC, Souza TM, et al. Clinical manifestations of zika virus Infection, Rio de Janeiro, Brazil, 2015. Emerg Infect Dis. 2016 ; 22 : 1318-20.
 
(7) Ioos S, Mallet HP, Leparc Goffart I, et al. Current Zika virus epidemiology and recent epidemics. Med Mal Infect. 2014 ; 44 : 302-7.
PubMed
(8) Paz-Bailey G, Rosenberg ES, Doyle K, et al. Persistence of Zika virus in body fluids-final report. N Engl J Med. 2018 ; 379 : 1234-43.
PubMed
(9) Driggers RW, Ho CY, Korhonen EM, et al. Zika virus Infection with prolonged maternal viremia and fetal brain abnormalities. N Engl J Med. 2016 ; 374 : 2142-51.
PubMed
(10) Lanciotti RS, Kosoy OL, Laven JJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. 2008 ; 14 : 1232-9.
PubMed
(11) Cao-Lormeau VM, Blake A, Mons S, et al. Guillain-Barre syndrome outbreak associated with Zika virus infection in French Polynesia : a case-control study. Lancet. 2016 ; 387 : 1531-9.
PubMed
(12) Carteaux G, Maquart M, Bedet A, et al. Zika virus associated with Meningoencephalitis. N Engl J Med. 2016 ; 374 : 1595-6.
PubMed
(13) Mecharles S, Herrmann C, Poullain P, et al. Acute myelitis due to Zika virus infection. Lancet. 2016 ; 387 : 1481.
PubMed
(14) Costello A, Dua T, Duran P, et al. Defining the syndrome associated with congenital Zika virus infection. Bull World Health Organ. 2016 ; 94 : 406-406A.
PubMed
(15) Schuler-Faccini L, Ribeiro EM, Feitosa IM, et al. Possible association between Zika virus infection and microcephaly-Brazil, 2015. MMWR Morb Mortal Wkly Rep. 2016 ; 65 : 59-62.
PubMed
(16) de Paula Freitas B, de Oliveira Dias JR, Prazeres J, et al. Ocular findings in infants with microcephaly associated with presumed Zika virus congenital infection in Salvador, Brazil. JAMA Ophthalmol. 2016.
PubMed
(17) Mittal R, Fifer RC, Liu XZ. A possible association between hearing loss and Zika virus Infections. JAMA Otolaryngol Head Neck Surg. 2017.
PubMed
(18) Cauchemez S, Besnard M, Bompard P, et al. Association between Zika virus and microcephaly in French Polynesia, 2013-15 : a retrospective study. Lancet. 2016 ; 387 : 2125-32.
PubMed
(19) Brasil P, Pereira JP Jr, Moreira ME, et al. Zika virus infection in pregnant women in Rio de Janeiro. N Engl J Med. 2016 ; 375 : 2321-34.
 
(20) Hoen B, Schaub B, Funk AL, et al. Pregnancy outcomes after ZIKV infection in French Territories in the Americas. N Engl J Med. 2018 ; 378 : 985-94.
PubMed
(21) Rice ME, Galang RR, Roth NM, et al. Vital signs : Zika-associated birth defects and neurodevelopmental abnormalities possibly associated with congenital Zika virus Infection - U. S. Territories and Freely Associated States, 2018. MMWR Morb Mortal Wkly Rep. 2018 ; 67 (31) : 858-67.
PubMed
(22) Honein MA, Dawson AL, Petersen EE, et al. Birth defects among fetuses and infants of US women with evidence of possible Zika virus infection during pregnancy. JAMA. 2017 ; 317 : 59-68.
PubMed
(23) Foy BD, Kobylinski KC, Chilson Foy JL, et al. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg Infect Dis. 2011 ; 17 : 880-2.
PubMed
(24) Musso D, Roche C, Robin E, et al. Potential sexual transmission of Zika virus. Emerg Infect Dis. 2015 ; 21 : 359-61.
PubMed
(25) Murray KO, Gorchakov R, Carlson AR, et al. Prolonged detection of Zika virus in vaginal secretions and whole blood. Emerg Infect Dis. 2017 ; 23 : 99-101.
PubMed
(26) Davidson A, Slavinski S, Komoto K, et al. Suspected female-to-male sexual transmission of Zika virus - New York City, 2016. MMWR Morb Mortal Wkly Rep. 2016 ; 65 : 716-7.
PubMed
(27) Barzon L, Pacenti M, Franchin E, et al. Infection dynamics in a traveller with persistent shedding of Zika virus RNA in semen for six months after returning from Haiti to Italy, January 2016. Euro Surveill. 2016 ; 21 (32).
 
(28) Nicastri E, Castilletti C, Liuzzi G, et al. Persistent detection of Zika virus RNA in semen for six months after symptom onset in a traveller returning from Haiti to Italy, February 2016. Euro Surveill. 2016 ; 21 (32).
 
(29) Mead PS, Duggal NK, Hook SA, et al. Zika Virus Shedding in Semen of Symptomatic Infected Men. N Engl J Med. 2018 ; 378 : 1377-85.
 
(30) Brooks RB, Carlos MP, Myers RA, et al. Likely sexual transmission of Zika virus from a man with no symptoms of infection-Maryland, 2016-MMWR Morbidity and mortality weekly report. 2016 ; 65 : 915-6
 
(31) Freour T, Mirallie S, Hubert B, et al. Sexual transmission of Zika virus in an entirely asymptomatic couple returning from a Zika epidemic area, France, April 2016. Euro Surveill. 2016 ; 21 (23) : pii=30254
 
(32) Polen KD, Gilboa SM, Hills S, et al. Update : lnferim guidance for preconception courseling and prevention of sexual transmission of Zika virus for men with possible Zika virus exposure-United States, August 2018. MMWR Morpidity and mortality weekly report. 2018 ; 67 : 868-71.
 
P.273 掲載の参考文献
(1) Kutsuna S, Kato Y, Takasaki T, et al. Two cases of Zika fever imported from French Polynesia to Japan, December 2013 to January 2014 [corrected]. Euro Surveill. 2014 ; 19 (4).
 
(2) Kutsuna S, Kato Y, Moi ML, et al. Autochthonous dengue fever, Tokyo, Japan, 2014. Emerg Infect Dis. 2015 ; 21 : 517.
PubMed
(3) Kutsuna S, Kawabata H, Kasahara K, et al. The first case of imported relapsing fever in Japan. Am J Trop Med Hyg. 2013 ; 89 : 460-1.
PubMed
(4) Kutsuna S, Kawabata H, Shiga N, et al. [Second Japanese case of relapsing fever]. Kansenshogaku Zasshi. 2014 ; 88 : 713-4.
PubMed
(5) Shinohara K, Kutsuna S, Takasaki T, et al. Zika fever imported from Thailand to Japan, and diagnosed by PCR in the urines. J Travel Med. 2016 ; 23 (1).
PubMed
(6) Kutsuna S, Ohmagari N, Tanizaki R, et al. The first case of adult-onset PFAPA syndrome in Japan. Modern Rheumatology. 2016 ; 26 : 286-7.
PubMed
(7) Tanizaki R, Kato Y, Iwagami M, et al. Performance of rapid diagnostic tests for Plasmodium ovale Malaria in Japanese travellers. Trop Med Health. 2014 ; 42 : 149-53.
PubMed
(8) Tsuboi M, Kutsuna S, Kato Y, et al. Autochthonous Chikungunya fever in traveler returning to Japan from Cuba. Emerg Infect Dis. 2016 ; 22 : 1683-5.
PubMed
(9) Takaya S, Kutsuna S, Nakayama E, et al. Chikungunya fever in traveler from Angola to Japan, 2016. Emerg Infect Dis. 2017 ; 23 : 156-8.
PubMed
(10) Schmidt-Chanasit J, Emmerich P, Tappe D, et al. Autochthonous dengue virus infection in Japan imported into Germany, September 2013. Euro Surveill. 2014 ; 19 (3)
 
P.275 掲載の参考文献
(1) 厚生労働省 福岡検疫所. https://www.forth.go.jp/keneki/fukuoka/kenekigyoumu.html
 

Q 海外での入院歴は要注意 !

P.281 掲載の参考文献
(1) Hayakawa K, Mezaki K, Sugiki Y, et al. High rate of multidrug-resistant organism colonization among patients hospitalized overseas highlights the need for preemptive infection control. Am J Infect Control. 2016 ; 44 : e257-e9.
PubMed
(2) Hashimoto A, Nagamatsu M, Ohmagari N, et al. Isolation of OXA-48 carbapenemase-producing Klebsiella pneumoniae ST101 from an overseas traveler returning to Japan. Jpn J Infect Dis. 2014 ; 67 : 120-1.
PubMed
(3) Lepelletier D, Andremont A, Grandbastien B, et al. Risk of highly resistant bacteria importation from repatriates and travelers hospitalized in foreign countries : about the French recommendations to limit their spread. J Travel Med. 2011 ; 18 : 344-51.
PubMed
(4) Laupland KB, Church DL, Vidakovich J, et al. Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli : importance of international travel. J Infect. 2008 ; 57 : 441-8.
PubMed
(5) Kantele A, Laaveri T, Mero S, et al. Antimicrobials increase travelers' risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae. Clin Infect Dis. 2015 ; 60 : 837-46.
PubMed
(6) 早川佳代子, 守山祐樹, 井手聡, 他. 医療機関における海外からの高度耐性菌の持ち込み対策ガイダンス. http://dcc.ncgm.go.jp/prevention/resource/resource.html
 

R 海外で犬に咬まれたら

P.293 掲載の参考文献
(1) 厚生労働省. 狂犬病. https://www.mhlw.go.jp/bunya/kenkou/kekkakukansenshou10/
 
(2) World Health Organization. WHO expert consultation on rabies. WHO Tech Rep Ser. 2005 ; Abstract 931, pg. 88.
 
(3) The World Health Organization. Rabies. Epidemiology and burden of disease. http://www.who.int/rabies/epidemiology/en/ (Accessed on September 26, 2018)
 
(4) Gode GR, Saksena R, Batra RK, et al. Treatment of 54 clinically diagnosed rabies patients with two survivals. Indian J Med Res. 1988 ; 88 : 564-6.
PubMed
(5) World Health Organization : WHO position paper on rabies vaccines. Wkly Epidemiol Rec. 2010 ; 85 : 309-20. http://www.who.int/wer/2010/wer8532.pdf
 
(6) Goldstein EJ. Bites. In : Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 8th ed. Philadelphia : Churchill Livingstone ; 2014 p. 3510-5.
 
(7) Kretsinger K, Broder KR, Cortese MM, et al. Preventing tetanus, diphtheria, and pertussis among adults : use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine MMWR. Recomm Rep. 2006 ; 55 (RR-17) : 1-37
 
(8) Gowda VK, Basavaraja GV, Reddy H, et al. Paralytic rabies following cat scratch and intra-dermal anti-rabies vaccination. J Pediatr Neurosci. 2014 ; 9 : 154-5.
PubMed
(9) Rabies vaccines : WHO position paper-April 2018.
 
(10) 高山直秀, 菅沼明彦, 笠井大介, 他. 外国製狂犬病ワクチンに引き続き国産狂犬病ワクチンで狂犬病曝露後発病予防を受けた人々における抗狂犬病抗体価. 感染症学雑誌. 2002 ; 76 : 882-7.
 
(11) 乾燥組織培養不活化狂犬病ワクチン添付文書. http://database.japic.or.jp/pdf/newPINS/00000280.pdf
 
(12) Rupprecht CE, Briggs D, Brown CM, et al ; Centers for Disease Control and Prevention (CDC). Use of a reduced (4-dose) vaccine schedule for postexposure prophylaxis to prevent human rabies : recommendations of the advisory committee on immunization practices. MMWR Recomm Rep. 2010 ; 59 (RR-2) : 1-9.
PubMed
(13) 高山直秀. 当院で狂犬病曝露後免疫を受けた咬傷被害者における抗狂犬病抗体産生. 感染症学雑誌. 1998 ; 72 : 1046-9.
 
(14) Benjavongkulchai M, Kositprapa C, Limsuwun K, et al. An immunogenicity and efficacy study of purified chick embryo cell culture rabies vaccine manufactured in Japan. Vaccine. 1997 ; 15 : 1816-9.
PubMed
(15) 竹下望, 金川修造, 藤谷好弘, 他. Travel related health problems in a travel clinic in Tokyo for 8 years. 第88回日本感染症学会学術講演会 第62回日本化学療法学会総会.
 
P.294 掲載の参考文献
(1) Cohen JI, Davenport DS, Stewart JA, et al. Recommendations for prevention of and therapy for exposure to B virus (Cercopithecine herpesvirus 1). Clin Infect Dis. 2002 ; 35 : 1191-203.
 
(2) Sinclair HA, Chapman P, Omaleki L, et al. Identification of Lonepinella sp. in Koala Bite Wound Infections, Queensland, Australia.
PubMed

S 渡航歴がなくても

P.314 掲載の参考文献
(1) Kutsuna S, Kato Y, Moi ML, et al. Autochthonous dengue fever, Tokyo, Japan, 2014. Emerg Infect Dis. 2015 ; 21 : 517-20.
PubMed
(2) 厚生労働省. デング熱国内感染事例発生時の対応・対策の手引き 地方公共団体向け (第1版).
 
(3) Kobayashi M, Komagata O, Yonejima M, et al. Retrospective search for dengue vector mosquito Aedes albopictus in areas visited by a German traveler who contracted dengue in Japan. Int J Infect Dis. 2014 ; 26 : 135-7.
 
(4) 国立感染症研究所感染症情報センター. 日本で診断されるデング熱症例数の季節的変化とその感染国の流行季節の影響について. IASR. 2011 ; 32 : 162-3. http://idsc.nih.go.jp/iasr/32/376/dj3762.html
 
(5) 静岡県健康福祉部 医療健康局疾病対策課. デング熱の国内感染症例 (県内2例目) の遺伝子検査 結果について. http://www.pref.shizuoka.jp/kinkyu/documents/140929_kisyahappyousiryou.pdf
 
(6) Schmidt-Chanasit J, Emmerich P, Tappe D, et al. Autochthonous dengue virus infection in Japan imported into Germany, September 2013. Euro Surveill. 2014 ; 19 : 20681.
 
(7) Senda A, Sakuntabhai A, Inaida S, et al. Estimating frequency of probable autochthonous cases of dengue, Japan. Emerg Infect Dis. 2018 ; 24 : 1705-8.
PubMed
(8) Kutsuna S, Kato Y, Moi ML, et al. Autochthonous dengue fever, Tokyo, Japan, 2014. Emerg Infect Dis. 2015 ; 21 : 517-20.
PubMed
(9) 篠原浩, 忽那賢志, 加藤康幸, 他. デング熱国内感染疑い症例の後方視的検討. 感染症学雑誌. 2017 ; 91 : 930-5.
 
(10) Kutsuna S, Hayakawa K, Kato Y, et al. The usefulness of serum C-reactive protein and total bilirubin levels for distinguishing between dengue fever and malaria in returned travelers. Am J Trop Med Hyg. 2014 ; 90 : 444-8.
 
(11) 厚生労働省. デング熱診療マニュアル (第1版). 2014年9月3日. http://www.mhlw.go.jp/bunya/kenkou/kekkaku-kansenshou19/dl/20140903-09.pdf
 
(12) 依田清江, 小岩井健司. 千葉県内で発生したパラチフスの集団事例について. IASR. 1999 ; 20 : 7. http://idsc.nih.go.jp/iasr/20/233/dj233a.html
 
(13) 荒木飛呂彦, 鬼窪浩久. 変人偏屈列伝. 東京 : 集英社 ; 2004.
 
P.316 掲載の参考文献
(1) Schmidt-Chanasit J, Emmerich P, Tappe D, et al. Autochthonous dengue virus infection in Japan imported into Germany, September 2013. Euro Surveill. 2014 ; 19 : 20681.
 

T 鳥に気をつけろッ !

P.327 掲載の参考文献
(1) Wiersinga WJ, Currie BJ, Peacock SJ. Melioidosis. N Engl J Med. 2012 ; 367 : 1035-44.
PubMed
(2) Soda K, Ito H, Usui T, et al. Incursion and spread of H5N1 highly pathogenic avian influenza viruses among wild birds in 2010-11 winter in Japan. J Vet Med Sci. 2013 ; 75 : 605-12.
PubMed
(3) Organization WH. WHO rapid advice guidelines on pharmacological management of humans infected with avian influenza A (H5N1) virus. Geneva : World Health Organization ; 2006.
 
(4) Ungchusak K, Auewarakul P, Dowell SF, et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med. 2005 ; 352 : 333-40.
PubMed
(5) Kandun IN, Wibisono H, Sedyaningsih ER, et al. Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med. 2006 ; 355 : 2186-94.
PubMed
(6) Interim Guidance for Infection Control Within Healthcare Settings When Caring for Confirmed Cases, Probable Cases, and Cases Under Investigation for Infection with Novel Influenza A Viruses Associated with Severe Disease. Centers for Disease Control and Prevention ; 2014.
 
(7) Clinical management of human infection with avian influenza A (H5N1) virus. Updated advice 15 August 2007.
 
(8) Wu J, Ke C, Lau EHY, et al. Influenza H5/H7 virus vaccination in poultry and reduction of zoonotic infections, Guangdong Province, China, 2017-18. Emerg Infect Dis. 2019 ; 25 : 116-8.
PubMed

U ウイルス性出血熱

P.352 掲載の参考文献
(1) Bishop AA. Investigation of Biological, Sociological, and Statistical Factors Contributing to the Emergence and Spread of the 2014 Ebola Virus Disease Outbreak in West Africa. 2016.
 
(2) Scott JT, Sesay FR, Massaquoi TA, et al. Post-Ebola syndrome, Sierra Leone. Emerg Infect Dis. 2016 ; 22 : 641.
PubMed
(3) Jagadesh S, Sevalie S, Fatoma R, et al. Disability among Ebola survivors and their close contacts in Sierra Leone : a retrospective case-controlled cohort study. Clin Infect Dis. 2017 ; 66 : 131-3.
 
(4) Clark DV, Kibuuka H, Millard M, et al. Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda : a retrospective cohort study. Lancet Infect Dis. 2015 ; 15 : 905-12.
PubMed
(5) Mate SE, Kugelman JR, Nyenswah TG, et al. Molecular evidence of sexual transmission of Ebola virus. N Engl J Med. 2015 ; 373 : 2448-54.
PubMed
(6) Deen GF, Broutet N, Xu W, et al. Ebola RNA persistence in semen of Ebola virus disease survivors. N Engl J Med. 2017 ; 377 : 1428-37.
PubMed
(7) Jacobs M, Rodger A, Bell DJ, et al. Late Ebola virus relapse causing meningoencephalitis : a case report. Lancet. 2016 ; 388 : 498-503.
PubMed
(8) Dokubo EK, Wendland A, Mate SE, et al. Persistence of Ebola virus after the end of widespread transmission in Liberia : an outbreak report. Lancet Infect Dis. 2018 ; 18 : 1015-24.
PubMed
(9) Uyeki TM, Mehta AK, Davey Jr RT, et al. Clinical management of Ebola virus disease in the United States and Europe. N Engl J Med. 2016 ; 374 : 636-46.
PubMed
(10) Bray M, Mahanty S. Ebola hemorrhagic fever and septic shock. J Infect Dis. 2003 ; 188 : 1613-7.
PubMed
(11) Kreuels B, Wichmann D, Emmerich P, et al. A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med. 2014 ; 371 : 2394-401.
PubMed
(12) Qiu X, Wong G, Fernando L, et al. mAbs and Ad-vectored IFN-alpha therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms. Sci Transl Med. 2013 ; 5 : 207ra143.
 
(13) Pettitt J, Zeitlin L, Kim DH, et al. Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktail. Sci Transl Med. 2013 ; 5 : 199ra13.
 
(14) Qiu X, Wong G, Audet J, et al. Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp. Nature. 2014 ; 514 : 47-53.
PubMed
(15) Davey RT Jr, Dodd L, Proschan MA, et al. A randomized, controlled trial of ZMapp for Ebola virus infection. N Engl J Med. 2016 ; 375 : 1448-56.
PubMed
(16) Oestereich L, Ludtke A, Wurr S, et al. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model. Antiviral Res. 2014 ; 105 : 17-21.
 
(17) Smither SJ, Eastaugh LS, Steward JA, et al. Post-exposure efficacy of oral T-705 (favipiravir) against inhalational Ebola virus infection in a mouse model. Antiviral Res. 2014 ; 104 : 153-5.
 
(18) Bixler SL, Bocan TM, Wells J, et al. Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus. Antiviral Res. 2018 ; 151 : 97-104.
PubMed
(19) Sissoko D, Laouenan C, Folkesson E, et al. Experimental treatment with favipiravir for Ebola virus disease (the JIKI trial) : a historically controlled, single-arm proof-of-concept trial in Guinea. PLoS Med. 2016 ; 13 : e1001967.
 
(20) Bai CQ, Mu JS, Kargbo D, et al. Clinical and virological characteristics of Ebola virus disease patients treated with favipiravir (T-705) -Sierra Leone, 2014. Clin Infect Dis. 2016 ; 63 : 1288-94.
PubMed
(21) van Griensven J, Edwards T, de Lamballerie X, et al. Evaluation of convalescent plasma for Ebola virus disease in Guinea. N Engl J Med. 2016 ; 374 : 33-42.
PubMed
(22) Corti D, Misasi J, Mulangu S, et al. Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody. Science. 2016 ; 351 : 1339-42.
PubMed
(23) Warren TK, Jordan R, Lo MK, et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature. 2016 ; 531 : 381-5.
PubMed
(24) Madrid PB, Chopra S, Manger ID, et al. A systematic screen of FDA-approved drugs for inhibitors of biological threat agents. PLoS One. 2013 ; 8 : e60579.
PubMed
(25) Gignoux E, Azman AS, de Smet M, et al. Effect of artesunate-amodiaquine on mortality related to Ebola virus disease. N Engl J Med. 2016 ; 374 : 23-32.
PubMed
(26) Yilmaz GR, Buzgan T, Irmak H, et al. The epidemiology of Crimean-Congo hemorrhagic fever in Turkey, 2002-2007. Int J Infect Dis. 2009 ; 13 : 380-6.
PubMed
(27) Team WER. Ebola virus disease in West Africa-the first 9 months of the epidemic and forward projections. N Engl J Med. 2014 ; 371 : 1481-95.
 
(28) Bodur H, Akinci E, Ascioglu S, et al. Subclinical infections with Crimean-Congo hemorrhagic fever virus, Turkey. Emerg Infect Dis. 2012 ; 18 : 640-2.
PubMed
(29) エボラ出血熱流行地からの帰国者 における熱帯熱マラリア症例. IASR. 2015 ; 36 : 1-2.
 
(30) 一般市中病院に来院した西アフリカからの帰国者における熱帯熱マラリアの一例. IASR. 2014 ; 35 : 274-5.
 
(31) McCormick JB, King IJ, Webb PA, et al. Lassa fever. Effective therapy with ribavirin. N Engl J Med. 1986 ; 314 : 20-6.
PubMed
(32) Elaldi N, Bodur H, Ascioglu S, et al. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever : a quasi-experimental study from Turkey. J Infect. 2009 ; 58 : 238-44.
 
(33) Ceylan B, Calica A, Ak O, et al. Ribavirin is not effective against Crimean-Congo hemorrhagic fever : observations from the Turkish experience. Int J Infect Dis. 2013 ; 17 : e799-801.
 
(34) Ergonul O, Keske S, Celdir MG, et al. Systematic review and meta-analysis of postexposure prophylaxis for Crimean-Congo hemorrhagic fever virus among healthcare workers. Emerg Infect Dis. 2018 ; 24 : 1642-8.
PubMed
(35) Organization WH. Health worker Ebola infections in Guinea, Liberia and Sierra Leone : a preliminary report. 2015.
 
(36) Negredo A, de la Calle-Prieto F, Palencia-Herrejon E, et al. Autochthonous Crimean-Congo hemorrhagic fever in Spain. N Engl J Med. 2017 ; 377 : 154-61.
 
(37) WHO Guidelines Approved by the Guidelines Review Committee. Personal Protective Equipment in the Context of Filovirus Disease Outbreak Response : Rapid Advice Guideline. Geneva : World Health Organization ; 2014.
 
(38) Kutsuna S, Yamamoto K, Takeshita N, et al. Experiences of response measures against the 4 suspected cases of Ebola virus disease from West Africa in the National Center for Global Health and Medicine, Tokyo, Japan. Jpn J Infect Dis. 2018 ; 71 : 62-4.
PubMed
P.356 掲載の参考文献
(1) 人獣共通感染症連続講座 第92回 ウイルス性出血熱に関する最近の話題 : エボラウイルスの宿主 ; ドイツでのラッサ熱患者 https://www.primate.or.jp/forum/
 
(2) 山内一也. エマージングウイルスの世紀. 河出書房新社.
 
(3) Jacobs M, Rodger A, Bell DJ, et al. Late Ebola virus relapse causing meningoencephalitis : a case report. Lancet. 2016 ; 388 : 498-503.
PubMed
(4) Hirabayashi Y, Oka S, Goto H, et al. The first imported case of Lassa fever in Japan. Nihon Rinsho. 1989 ; 47 : 71-5.
PubMed

V バイオテロって起こりえますか ?

P.370 掲載の参考文献
(1) Casey JR, Pichichero ME. Meta-analysis of cephalosporins versus penicillin for treatment of group A Streptococcal tonsillopharyngitis in adults. Clin Infect Dis. 2004 ; 38 : 1526-34.
 
(2) Erdem H, Elaldi N, Ak O, et al. Genitourinary brucellosis : results of a multicentric study. Clin Microbiol Infect. 2014 ; 20 : O847-53.
PubMed
(3) Pappas G, Papadimitriou P, Akritidis N, et al. The new global map of human brucellosis. Lancet Infect Dis. 2006 ; 6 : 91-9.
PubMed
(4) Yamamoto K, Kato Y, Mutoh Y, et al. A traveler from Africa with fever and aggravated chronic back pain. Clin Infect Dis. 2018 ; 66 : 806-7.
 
(5) 今岡浩一. ブルセラ症の最近の話題. モダンメディア. 2009 ; 55 : 77-85.
 
(6) 新規ブルセラ属菌によるブルセラ症と診断された日本人男性の一例. IASR. 2018 ; 39 : 84-6.
 
(7) Sayin-Kutlu S, Kutlu M, Ergonul O, et al. Laboratory-acquired brucellosis in Turkey. J Hospit Infect. 2012 ; 80 : 326-30.
 
(8) Traxler RM, Lehman MW, Bosserman EA, et al. A literature review of laboratory-acquired brucellosis. J Clin Microbiol. 2013 ; 51 : 3055-62.
PubMed

W ガチなヤツに気をつけろッ !

P.384 掲載の参考文献
(1) 忽那賢志. 「だいたいウンコになる」抗菌薬にご用心! 感染症相談室. Aナーシング. 2015.
 
(2) 杉田隆, 張音実. 国内で初めて確定されたCryptococcus gattii genotype VGIIa株による感染例について. IASR. 2015 ; 36 : 187-8.
 
(3) MacDougall L, Kidd SE, Galanis E, et al. Spread of Cryptococcus gattii in British Columbia, Canada, and detection in the Pacific Northwest, USA. Emerg Infect Dis. 2007 ; 13 : 42-50.
PubMed
(4) 亀井克彦. 輸入真菌症とその問題点. Medical Mycology Journal. 2012 ; 53 : 103-8.
 
(5) Stefan S, et al. Advances in the diagnosis and treatment of fungal infections of the CNS. Lancet Neurol. 2018.
 

X 結核を見逃すなッ !

P.398 掲載の参考文献
(1) 輸入感染症としての結核. IASR. 2017 ; 38 : 234-5.
 
(2) Abubakar I. Tuberculosis and air travel : a systematic review and analysis of policy. Lancet Infect Dis. 2010 ; 10 : 176-83.
PubMed
(3) WHO. Tuberculosis and air travel : guidelines for prevention and control : World Health Organization ; 2008.
 
(4) Izumi K, Ohkado A, Uchimura K, et al. Detection of tuberculosis infection hotspots using activity spaces based spatial approach in an urban Tokyo, from 2003 to 2011. Plos One. 2015 ; 10 (9) : e0138831.
 

Y MERSに気をつけろッ !

P.409 掲載の参考文献
(1) Azhar EI, El-Kafrawy SA, Farraj SA, et al. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med. 2014 ; 370 : 2499-505.
PubMed
(2) Alshukairi AN, Zheng J, Zhao J, et al. High prevalence of MERS-CoV infection in camel workers in Saudi Arabia. mBio. 2018 ; 9 ; pil : e01985-18.
 
(3) Reusken CB, Farag EA, Jonges M, et al. Middle East respiratory syndrome coronavirus (MERS-CoV) RNA and neutralising antibodies in milk collected according to local customs from dromedary camels, Qatar, April 2014. Euro Surveill. 2014 ; 19 ; pil : 20829.
 
(4) Drosten C, Meyer B, Muller MA, et al. Transmission of MERS-coronavirus in household contacts. N Engl J Med. 2014 ; 371 : 828-35.
PubMed
(5) Oboho IK, Tomczyk SM, Al-Asmari AM, et al. 2014 MERS-CoV outbreak in Jeddah--a link to health care facilities. N Engl J Med. 2015 ; 372 : 846-54.
PubMed
(6) Park HY, Lee EJ, Ryu YW, et al. Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. Euro Surveill. 2015 ; 20 : 1-6.
 
(7) Guery B, Poissy J, el Mansouf L, et al. Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus : a report of nosocomial transmission. Lancet. 2013 ; 381 : 2265-72.
PubMed
(8) Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia : a descriptive study. Lancet Infect Dis. 2013 ; 13 : 752-61.
PubMed
(9) Infection prevention and control during health care for probable or confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection Interim guidance Updated 4 June 2015.
 
(10) Control CfD, Prevention. Interim infection prevention and control recommendations for hospitalized patients with Middle East respiratory syndrome coronavirus (MERS-CoV). 2015.
 

Z 最終試験

P.434 掲載の参考文献
(1) Gugliotta JL, Goethert HK, Berardi VP, et al. Meningoencephalitis from Borrelia miyamotoi in an immunocompromised patient. N Engl J Med. 2013 ; 368 : 240-5.
 
(2) Hovius JW, de Wever B, Sohne M, et al. A case of meningoencephalitis by the relapsing fever spirochaete Borrelia miyamotoi in Europe. Lancet. 2013 ; 382 : 658.
PubMed
(3) Chowdri HR, Gugliotta JL, Berardi VP, et al. Borrelia miyamotoi infection presenting as human granulocytic anaplasmosis : a case report. Ann Intern Med. 2013 ; 159 : 21-7.
PubMed
(4) Platonov AE, Karan LS, Kolyasnikova NM, et al. Humans infected with relapsing fever spirochete Borrelia miyamotoi, Russia. Emerg Infect Dis. 2011 ; 17 : 1816.
PubMed
(5) Sato K, Takano A, Konnai S, et al. Human infections with Borrelia miyamotoi, Japan. Emerg Infect Dis. 2014 ; 20 : 1391.
PubMed
(6) Takano A, Toyomane K, Konnai S, et al. Tick surveillance for relapsing fever spirochete Borrelia miyamotoi in Hokkaido, Japan. PLoS One. 2014 ; 9 : e104532.
PubMed
(7) Fournier P-E, Fujita H, Takada N, et al. Genetic identification of Rickettsiae isolated from ticks in Japan. J Clin Microbiol. 2002 ; 40 : 2176-81.
PubMed
P.436 掲載の参考文献
(1) Takano A, Muto M, Sakata A, et al. Relapsing fever spirochete in seabird tick, Japan. Emerg Infect Dis. 2009 ; 15 : 1528.
PubMed
P.445 掲載の参考文献
(1) Urech K, Neumayr A, Blum J. Sleeping sickness in travelers-do they really sleep? PLoS Negl Trop Dis. 2011 ; 5 : e1358.
PubMed
(2) To F. Fever of unknown origin : a clinical approach. UBC Medical Journal. 2013 ; 4 (2).
 
(3) Nishihara E, Ohye H, Amino N, et al. Clinical characteristics of 852 patients with subacute thyroiditis before treatment. Intern Med. 2008 ; 47 : 725-9.
PubMed
(4) Kutsuna S, Kawabata H, Kasahara K, et al. The first case of imported relapsing fever in Japan. Am J Trop Med Hyg. 2013 ; 89 : 460-1.
PubMed
(5) 忽那賢志, 川端寛樹, 志賀尚子, 他. 日本人2例目となる回帰熱症例. 感染症学雑誌. 2014 ; 88 : 713-4.
 
(6) Parola P, Raoult D. Ticks and tickborne bacterial diseases in humans : an emerging infectious threat. Clinical Infect Dis. 2001 ; 32 : 897-928.
 
(7) Walker DH. Rickettsiae and rickettsial infection : the current state of knowledge. Clin Infect Dis. 2007 ; 45 (Supplement. 1) : S39-S44.
 
(8) Weitzel T. Dittrich S, Lopez J, et al. Endemic scrub typhus in South America. N Engl J Med. 2016 ; 375 : 954-61.
PubMed

書評

最近チェックした商品履歴

Loading...